Conduent’s $1.52 stock offers distressed turnaround upside if Transportation proceeds, $100 million savings, and Medicaid growth overcome accelerating Commercial customer losses.
Overview
Conduent Inc. (CNDT) provides transaction-intensive digital business process services to Fortune 100 companies, financial institutions, healthcare payers, and more than 600 government entities. Its restructured portfolio is now concentrated in Commercial and Government, with Transportation classified as discontinued operations in Q2 2026. The Government segment, particularly Medicaid administration and EBT, has sticky contracts, embedded infrastructure, and significant switching costs, while Commercial CX remains exposed to contract attrition and lower-margin competition. **Q2 2026 exposed severe operating deterioration:** continuing-operations revenue fell 11.9% year over year to $531 million, substantially below consensus near $698.50–$702.00 million, and adjusted EBITDA declined 30.4% to $16 million. Management nevertheless expects restructuring benefits and guided to 2026 continuing revenue of $2,150–$2,250 million and adjusted EBITDA of $140–$170 million. The pending Transportation divestitures could produce approximately $234 million of gross proceeds for debt reduction, while the restructuring targets at least $100 million of annualized savings by H1 2027. At $1.52, CNDT trades at 0.1x sales, but the balance sheet, negative free cash flow, and execution risk make it a speculative turnaround rather than a conventional value investment. The report’s probability-weighted five-year value is $5.58 per share.